Cathelicidins have been proposed to have multiple inflammomodulatory properties that could modulate the clearance of infection in vivo[2], including direct chemotactic activity of LL-37 for neutrophils and monocytes [34], [35], [36], [37], [38]. The gene discussed is CAMP; the disease is infection.